{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:48:10Z","timestamp":1782276490180,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017218","name":"Giresun \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.exer.2026.110912","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:39:38Z","timestamp":1770565178000},"page":"110912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of chemokine and chemokine-receptor gene polymorphisms on the development of diabetic retinopathy in the Turkish cohort"],"prefix":"10.1016","volume":"266","author":[{"given":"Ebru","family":"Alp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egemen","family":"Akgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Doguizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadime Mutlu","family":"Icduygu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Sekeroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat Atabey","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.exer.2026.110912_bib1","first-page":"155","article-title":"Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy","volume":"17","author":"Abu El-Asrar","year":"2006","journal-title":"Eur. Cytokine Netw."},{"issue":"12","key":"10.1016\/j.exer.2026.110912_bib2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s00417-008-0868-6","article-title":"Assessment of selected adhesion molecule and proinfammatory cytokine levels in the vitreous body of patients with type 2 diabetes\u2013role of the infammatory-immune process in the pathogenesis of proliferative diabetic retinopathy","volume":"246","author":"Adamiec-Mroczek","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2026.110912_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00281-008-0111-x","article-title":"Immunological mechanisms in the pathogenesis of diabetic retinopathy","volume":"30","author":"Adamis","year":"2008","journal-title":"Semin. Immunopathol."},{"issue":"22","key":"10.1016\/j.exer.2026.110912_bib4","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.exer.2026.110912_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/frne.2001.0214","article-title":"Chemokines and their receptors in the central nervous system","volume":"22","author":"Bajetto","year":"2001","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.exer.2026.110912_bib6","first-page":"1012","article-title":"Genetic variant A-2518G of the MCP-1 is not related to microvascular complications of type 2 diabetes mellitus in mexican-mestizo subjects","volume":"2","author":"Benitez","year":"2020","journal-title":"Biomed. Res. Health Adv"},{"issue":"7","key":"10.1016\/j.exer.2026.110912_bib7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/bjo.2006.090357","article-title":"Localisation of SDF-1 and its receptor CXCR4 in retina and choroid of aged human eyes and in eyes with age related macular degeneration","volume":"90","author":"Bhutto","year":"2006","journal-title":"Br. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2026.110912_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/bjo.82.5.561","article-title":"VEGF localisation in diabetic retinopathy","volume":"82","author":"Boulton","year":"1998","journal-title":"Br. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.exer.2026.110912_bib9","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1167\/iovs.13-12518","article-title":"Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous","volume":"54","author":"Bromberg-White","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2026.110912_bib10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI22869","article-title":"SDF-1 is both necessary and sufficient to promote proliferative retinopathy","volume":"115","author":"Butler","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.exer.2026.110912_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/09273940490518900","article-title":"Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy","volume":"13","author":"Canataroglu","year":"2005","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"8","key":"10.1016\/j.exer.2026.110912_bib12","first-page":"984","article-title":"Expression of stromal cell-derived factor-1 in diabetic retinopathy","volume":"123","author":"Chen","year":"2010","journal-title":"Chin. Med. J. (Engl. Ed.)"},{"issue":"3","key":"10.1016\/j.exer.2026.110912_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2003.10.009","article-title":"CCL2 (monocyte chemoattractant protein-1) and cancer","volume":"14","author":"Conti","year":"2004","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.exer.2026.110912_bib14","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/09168451.2019.1588095","article-title":"Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 improves diabetic retinopathy","volume":"83","author":"Deng","year":"2019","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"1","key":"10.1016\/j.exer.2026.110912_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1167\/iovs.07-0656","article-title":"Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration","volume":"49","author":"Despriet","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2026.110912_bib16","first-page":"11","article-title":"Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients","volume":"19","author":"Dimberg","year":"2007","journal-title":"Int. J. Mol. Med."},{"issue":"12","key":"10.1016\/j.exer.2026.110912_bib17","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00417-014-2651-1","article-title":"Association of monocyte chemoattractant protein-1 (MCP-1)2518A\/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes","volume":"252","author":"Dong","year":"2014","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"15","key":"10.1016\/j.exer.2026.110912_bib18","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.3390\/ijms25158036","article-title":"Association of SDF-1-3' gene A variant with diabetic retinopathy in the Hungarian population","volume":"25","author":"Ecsedy","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.exer.2026.110912_bib19","first-page":"22","article-title":"Association of Monocyte chemoattractant Protein-1 (MCP-1) 2518A\/G gene polymorphism with proliferative diabetic retinopathy in patients with type 2 diabetes","volume":"12","author":"Foda","year":"2015","journal-title":"Life Sci. J."},{"issue":"7","key":"10.1016\/j.exer.2026.110912_bib20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/aje\/kwx228","article-title":"Update on the state of the science for analytical methods for gene-environment interactions","volume":"186","author":"Gauderman","year":"2017","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.exer.2026.110912_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2015.01.002","article-title":"The +190 G\/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1\u221715:01-negative individuals","volume":"349","author":"Javor","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.exer.2026.110912_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3349\/ymj.2013.54.3.621","article-title":"Association of monocyte chemoattractant protein-1 (MCP-1) 2518A\/G polymorphism with proliferative diabetic retinopathy in Korean type 2 diabetes","volume":"54","author":"Jeon","year":"2013","journal-title":"Yonsei Med. J."},{"issue":"1","key":"10.1016\/j.exer.2026.110912_bib23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/dme.12804","article-title":"Elevated serum monocyte chemoattractant protein-1 levels and its genetic polymorphism is associated with diabetic retinopathy in Chinese patients with type 2 diabetes","volume":"33","author":"Jiang","year":"2016","journal-title":"Diabet. Med."},{"issue":"12","key":"10.1016\/j.exer.2026.110912_bib24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","volume":"18","author":"Joussen","year":"2004","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.exer.2026.110912_bib25","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.diabres.2010.04.006","article-title":"Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes","volume":"89","author":"Katakami","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.exer.2026.110912_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00417-020-04889-0","article-title":"Vitreous levels of vascular endothelial growth factor, stromal cell-derived factor-1\u03b1, and angiopoietin-like protein 2 in patients with active proliferative diabetic retinopathy","volume":"259","author":"Keles","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"12","key":"10.1016\/j.exer.2026.110912_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/02713680701758727","article-title":"Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion","volume":"32","author":"Ki-I","year":"2007","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2026.110912_bib28","first-page":"159","article-title":"Levels of selected aqueous humor mediators (IL-10, IL-17, CCL2, VEGF, FasL) in diabetic cataract","volume":"24","author":"Mitrovi\u0107","year":"2016","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"6","key":"10.1016\/j.exer.2026.110912_bib29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2337\/db22-0619","article-title":"Transcriptomic profiling reveals chemokine CXCL1 as a mediator for neutrophil recruitment associated with blood-retinal barrier alteration in diabetic retinopathy","volume":"72","author":"Monickaraj","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2026.110912_bib30","first-page":"2749","article-title":"Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes","volume":"18","author":"Paine","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2026.110912_bib31","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3389\/fimmu.2020.01802","article-title":"Chemokines in non-alcoholic fatty liver disease: a systematic review and network metaanalysis","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.exer.2026.110912_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13098-024-01297-w","article-title":"Chemokines in diabetic eye disease","volume":"16","author":"Pan","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.exer.2026.110912_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1296773","article-title":"Association of SDF-1 and its receptor CXCR4 polymorphisms on the susceptibility of diabetic retinopathy in the Taiwanese population","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.exer.2026.110912_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-8-20","article-title":"Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians","volume":"8","author":"Prasad","year":"2007","journal-title":"BMC Med. Genet."},{"issue":"6","key":"10.1016\/j.exer.2026.110912_bib35","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/genes15060712","article-title":"PON1, APOE and SDF-1 gene polymorphisms and risk of retinal vein occlusion: a case-control study","volume":"15","author":"Ragkousis","year":"2024","journal-title":"Genes"},{"issue":"10","key":"10.1016\/j.exer.2026.110912_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108508","article-title":"Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy","volume":"9","author":"Rangasamy","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.exer.2026.110912_bib37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jdiacomp.2017.02.017","article-title":"Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy","volume":"31","author":"Reddy","year":"2017","journal-title":"J. Diabet. Complicat."},{"issue":"3","key":"10.1016\/j.exer.2026.110912_bib38","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s00125-022-05860-w","article-title":"CCR2-positive monocytes contribute to the pathogenesis of early diabetic retinopathy in mice","volume":"66","author":"Saadane","year":"2023","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.exer.2026.110912_bib39","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1167\/iovs.07-0456","article-title":"Curcumin modulates SDF-1alpha\/CXCR4-induced migration of human retinal endothelial cells (HRECs)","volume":"49","author":"Sameermahmood","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2026.110912_bib40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2337\/dc13-2002","article-title":"Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Sim\u00f3","year":"2014","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.exer.2026.110912_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166544","article-title":"Stromal cell-derived factor 1 polymorphism in retinal vein occlusion","volume":"11","author":"Szigeti","year":"2016","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.exer.2026.110912_bib42","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12079-018-00500-8","article-title":"Monocyte chemoattractant protein-1 (MCP-1\/CCL2) in diabetic retinopathy: latest evidence and clinical considerations","volume":"13","author":"Taghavi","year":"2019","journal-title":"J. Cell Commun. Signal."},{"issue":"6","key":"10.1016\/j.exer.2026.110912_bib43","doi-asserted-by":"crossref","first-page":"Bio68","DOI":"10.1167\/iovs.17-21769","article-title":"Local and systemic infammatory biomarkers of diabetic retinopathy: an integrative approach","volume":"58","author":"Vujosevic","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.110912_bib44","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.12659\/MSM.917186","article-title":"The effects of the CXCR4 antagonist, AMD3465, on human retinal vascular endothelial cells (hRVECs) in a high glucose model of diabetic retinopathy","volume":"25","author":"Wu","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"3","key":"10.1016\/j.exer.2026.110912_bib45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cyto.2004.01.005","article-title":"Polymorphisms of chemokine and chemokine receptor genes in type 1 diabetes mellitus and its complications","volume":"26","author":"Yang","year":"2004","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.exer.2026.110912_bib46","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4049\/jimmunol.142.6.1956","article-title":"Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes","volume":"142","author":"Yoshimura","year":"1989","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.exer.2026.110912_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.dsx.2009.07.008","article-title":"Monocyte chemoattractant protein-1 -2518 polymorphism is not associated with diabetic retinopathy in Japanese type 2 diabetes","volume":"3","author":"Yoshioka","year":"2009","journal-title":"Diabetes Metabol. Syndr.: Clin. Res. Rev."},{"key":"10.1016\/j.exer.2026.110912_bib48","first-page":"756","article-title":"Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion","volume":"25","author":"Zeng","year":"2019","journal-title":"Mol. Vis."},{"issue":"7","key":"10.1016\/j.exer.2026.110912_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0038918","article-title":"The-2518A\/G polymorphism in the MCP-1 gene and tuberculosis risk: a meta-analysis","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526000680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526000680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:10:18Z","timestamp":1782274218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526000680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"alternative-id":["S0014483526000680"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.110912","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of chemokine and chemokine-receptor gene polymorphisms on the development of diabetic retinopathy in the Turkish cohort","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.110912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110912"}}